Phase II Trial of FavId (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06.

Trial Profile

Phase II Trial of FavId (Patient-Specific Idiotype/KLH) and GM-CSF in Subjects Who Demonstrated Progressive Disease and Did Not Receive FavId on Study FavId-06.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2013

At a glance

  • Drugs Mitumprotimut T (Primary)
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Feb 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 27 Dec 2007 The expected completion date for this trial is 1 Jun 2011.
    • 01 Apr 2007 New trial centre added.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top